{"_id":"PUG7ZgRsQbbM8R7mEvVEHO969hCU1FoL5so9lmwUhSNko7TXlkrebZ","lastupdate":"2025-01-08T00:00:00.000Z","update_date":"2025-01-08T00:00:00.000Z","lastModified":"Jan 12, 2025","active":1,"confidence_score":58,"confidence_score_reason":"funding stage, product stage, sector, business model, video or image, funding rounds, markets, external profiles, not claimed","urlname":"ribox-therapeutics","minimal_profile":null,"status":"","fullstatus":null,"acquired":null,"hide_reason":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","hide_reason_data":{"reason":"No relevant activity","visible":0},"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$64VjICg3QN7x7AJ3gT0G15xzuvH4rlj2cclcWRlQ0QXzUMJVZdWjbM.png","name":"RiboX Therapeutics","oneliner":"Biotechnology","registrar":null,"website":"https://www.riboxtx.com","careerspage":"","founded_month":2,"founded_year":2022,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"1-10","employees_exact":10,"patent":null,"raised":null,"stage":"Pre-Funding","public_stage":"Pre-Funding","primary_sector_key":null,"primary_sector":"","alternativenames":null,"about":"RiboX is a biotechnology company specializing in the discovery and development of fully engineered circular RNA therapeutics—a new class of RNA medicines designed to overcome the limitations of traditional mRNA therapies. By focusing on circular RNA, RiboX aims to unlock the full potential of RNA-based treatments, offering innovative solutions for various medical conditions.\n\nGlobally, RiboX operates from its headquarters in Shanghai, China, with additional offices in Beijing, Princeton (USA), and Rehovot (Israel). The company collaborates with international research institutions and industry partners to advance its therapeutic platforms and bring cutting-edge treatments to the global market.\n\nIn Israel, RiboX's presence in Rehovot positions it within one of the country's leading hubs for scientific research and innovation. This strategic location enables RiboX to engage with Israel's vibrant biotech ecosystem, fostering collaborations with local universities, research centers, and biotech companies. Through these partnerships, RiboX contributes to the advancement of RNA-based therapeutics, leveraging Israel's renowned expertise in medical research and technology development.\n\nBy integrating global operations with local collaborations, RiboX is at the forefront of developing next-generation RNA medicines, striving to make significant contributions to healthcare worldwide and particularly within Israel.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":"China","address":{"israeli":[{"id":"y9khXP43pKt9NAy3iQfUI8ChBk3j7tnZS163OQDhSAcCo98YecRPMG","city":"Ness Ziona","type":["R&D"],"address":"Einstein St 18, Ness Ziona, Israel","placeid":"ChIJ2Zmf1O-2AhURJ_ej8Wn87lo","notactive":0,"openeddate":"2022-03-08","registrarid":"516590643","firstrdcenter":0,"registrarname":"RIBOX THERAPEUTICS (ISRAEL)"}],"officesabroad":[{"id":"8D6LiakvQOPvqJXQF0ZCybDBqBchQdlfWgMBBoQxz6KFqcyvFIEbiY","city":null,"address":"40 Xiao Yun Lu, Chao Yang Qu, Bei Jing Shi, China, 100000","country":"China","placeid":"ChIJmQLqy0qr8TURPZKP9-EaWBg"},{"id":"TXdvde6JSbhEC6fpVV8W7ZpMoJsaNWfgvgl0VILMehToZ9EVgKmg51","city":null,"address":"Sheng Rong Lu, Pu Dong Xin Qu, Shang Hai Shi, China, 201203","country":"China","placeid":"ChIJOcDNAhl4sjURH77vaomb_tw"},{"id":"vvGyUKQktR1g6iEKGcG9mN2fAx1bGabfTVWz46azf17J59aD80xL5P","city":"Princeton","address":"5 Vaughn Dr #308, Princeton, NJ 08540, USA","country":"United States","placeid":"Eio1IFZhdWdobiBEciAjMzA4LCBQcmluY2V0b24sIE5KIDA4NTQwLCBVU0EiHxodChYKFAoSCVNiXbna4MOJEXMLSJBT4rlIEgMzMDg"}]},"headquarter_address":"Sheng Rong Lu, Pu Dong Xin Qu, Shang Hai Shi, China, 201203","district":"Center District","news":[{"id":"BAQSdnIjhqYfmuC332CXkK816kzsEvNBGLPeZL3vA8ce6KbbC2HOCk","date":"Oct 25, 2024","link":"https://www.prnewswire.com/news-releases/ribox-therapeutics-announces-fda-clearance-for-ind-application-of-rxrg001-the-first-circular-rna-therapy-for-the-treatment-of-radiation-induced-xerostomia-and-hyposalivation-302287539.html","source":"www.prnewswire.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"FQ5kPR1j0APDNBi3cjWPWxZc0jqplttBgtpQyYZBlRB9o3eAmo9RqJ","news_summary":"RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation ","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"}],"newsNumber":1,"events":null,"techcommunityinvolvement":null,"mediagallery":[],"tags":["biotechnology","drug-delivery","in-vivo","nanotechnology"],"classificationIDs":[],"technologysuccessstory":null,"usecases":[],"businessmodels":[],"productstage":"","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Pre-Funding","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":null},"team":[{"name":"Dan Peer","email":"dan.peer@Ribox-tx.com","phone":"","gender":"Male","userid":"JGe3BfI2UuAoapGKL2UqhYh2jMWOK8IGorbQrZ0gnxqX7Y0SjPZ4w6","bounced":false,"claimed":null,"founder":1,"urlname":"dan-peer-1","visible":1,"memberid":"Px6U1UEQCPwP8C3AUKANzkiKkkQ6RScK6InKhtqA5RY5024YbgikVf","position":"Co-founder","last_name":"Peer","claimtoken":"ANuVNYr25adn1ut4EPc6mkMQAZzSh0Xy8V7mEO3qSgrs2pv4Shj8D0","first_name":"Dan","picturekey":"$7OaT2n4g77EA90C0TYlPtQ5bBgNSvfm5S2GTgEC2RHPfNYncOX5E5n.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/danpeer10/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2025-01-08 13:44:50.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$7OaT2n4g77EA90C0TYlPtQ5bBgNSvfm5S2GTgEC2RHPfNYncOX5E5n.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Edo Kon","email":"Edo.Kon@Ribox-tx.com","phone":"","gender":"Male","userid":"QnzCm6hMU74u2muWfOOqWH9SGXiac5Wh4hVPuHD7G9Wn49qlT54VNE","bounced":false,"claimed":null,"founder":0,"urlname":"edo-kon-edo-kon","visible":1,"memberid":"WT0Qu5ND2pG4ejyPFTivpwVNRh2RfwXrVPMBMk3dOyizLnyBXBUGkC","position":"Director of Business Development","last_name":"Kon","claimtoken":"fnOQr8roGNhUCPDHRhWMAW2WRvtfvxESQ5eHI7th2FmfhYXCAMCmun","first_name":"Edo","picturekey":"$Zmt1AiED8AmS3ccF5xp97c1YqbgGMbu1XyU6krUIBoNWqGuNIVS1Dv.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/edo-kon/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2025-01-08 13:44:52.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$Zmt1AiED8AmS3ccF5xp97c1YqbgGMbu1XyU6krUIBoNWqGuNIVS1Dv.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":null,"tag_line_edited":null,"sector":null,"sectorverify":null,"biverify":null,"biverifydate":"2025-01-12T00:00:00.000Z","crunchbaseid":"ribox-therapeutics","lastupdator":null,"lastupdator_email":null,"creator":"Jenny Sotnik-Talisman","creator_email":"jenny.sotnik@sncentral.org","createdate":"2025-01-08T00:00:00.000Z","biverification":null,"sectorverification":null,"affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"2/2022","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"RiboX Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$64VjICg3QN7x7AJ3gT0G15xzuvH4rlj2cclcWRlQ0QXzUMJVZdWjbM.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$64VjICg3QN7x7AJ3gT0G15xzuvH4rlj2cclcWRlQ0QXzUMJVZdWjbM.png","seoabout":"RiboX is a biotechnology company specializing in the discovery and development of fully engineered circular RNA therapeutics—a new class of RNA medicines d...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"classifications":[],"classificationDelimited":[],"classificationsViewModel":"|","classificationTrees":{"sector":[],"targetCustomer":[],"coreTechnology":[]},"sectorClassifications":[],"coreTechnologyClassifications":[],"targetCustomerClassifications":[],"classificationNames":{"sector":[],"coreTechnology":[],"targetCustomer":[]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}